⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Michael LevineMD

Cardiology · New Hyde Park, NY 11042

NPI: 1003948464

Share:

9

🟢 Low

Risk Flags

Opioid + benzodiazepine co-prescriber

Risk indicators are statistical patterns, not allegations. Learn more

12,100

Total Claims

$1.8M

Drug Cost

1,261

Beneficiaries

$1,410

Cost/Patient

Risk Score Breakdown 9/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid + benzodiazepine combo+8

Score components are additive. Read full methodology

Peer Comparison vs. 18,720 Cardiology providers

-7%

Cost per patient vs peers

$1,410 vs $1,524 avg

-2%

Brand preference vs peers

13.4% vs 13.7% avg

⚠️ Opioid + Benzodiazepine Co-Prescriber

This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.

🔎 Data Overview

⚠️

This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

0.4%

Opioid Rate

54

Opioid Claims

$911

Opioid Cost

Long-Acting Rate

Brand vs Generic

87% generic

Brand: 1,615 claims · $1.5M

Generic: 10,451 claims · $314K

Top Prescribed Drugs

Drug (Generic)ClaimsCost
Rivaroxaban429$457K
Apixaban268$302K
Sacubitril/Valsartan88$129K
Tirzepatide70$81K
Semaglutide53$69K
Dapagliflozin Propanediol45$45K
Empagliflozin36$41K
Sitagliptin Phosphate30$38K
Alirocumab25$35K
Pitavastatin Calcium38$31K
Evolocumab20$25K
Metoprolol Succinate821$21K
Ticagrelor20$19K
Diltiazem Hcl234$18K
Nebivolol Hcl138$14K

Prescribing Profile

131

Unique Drugs

$1.0M

IRA Negotiated Drugs

$149K

GLP-1 Drugs

9.0

Anomaly Score

Patient Profile

75

Avg Age

55%

Female

1.14

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About